A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). (Q44422362)
Jump to navigation
Jump to search
scientific article published in June 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). |
scientific article published in June 1996 |
Statements
1 reference
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). (English)
1 reference
1 reference
Kundu S
1 reference
Haslett PA
1 reference
Katzenstein D
1 reference
Beckett L
1 reference
Spino C
1 reference
Borucki M
1 reference
Vasquez M
1 reference
Smith G
1 reference
Korvick J
1 reference
Kagan J
1 reference
Merigan TC
1 reference
1 reference
Identifiers
1 reference